Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
08.09. | Servier to Acquire Kaerus Bioscience's Autism Drug in Potential $450M Deal | ||
05.09. | One2Treat Raises Capital with Seed Extension | ||
05.09. | Gilead Announces Partnership With PEPFAR | ||
05.09. | Gannet BioChem Promotes Bob Rodebaugh to VP of Technology | ||
04.09. | Enzene Opens New Biomanufacturing Facility in Hopewell, NJ | ||
04.09. | Allucent Expands Executive Team | ||
04.09. | BioFactura Establishes CDMO Division | ||
04.09. | Keystone Folding Box Co. Introduces Key-Pak Plus | ||
04.09. | Zydus, Synthon Enter Exclusive Licensing and Supply Pact for Ozanimod Capsules | ||
04.09. | MRM Health Closes $64M Series B Financing Round | ||
04.09. | Samuel Hernandez Named Site Head of TX Fujifilm Biotechnologies Facility | ||
04.09. | Gilead Breaks Ground on Pharmaceutical Development & Manufacturing Technical Development Center | ||
03.09. | Atelerix and Rodon Global Partner to Enhance Biomedical Logistics | ||
03.09. | Aptamer Group Partners with Invizius to Develop Next-Gen Complement System Therapies | ||
03.09. | Parabilis Medicines Names Fawzi Benzaghou Chief Medical Officer | ||
03.09. | Charles River Bolsters Cell Therapy Platform with Akadeum's T Cell Isolation Technology | ||
03.09. | Tobin Scientific Appoints Julia Bushell as Quality & Regulatory Affairs SVP | ||
03.09. | Ryvu Therapeutics to Support Clinical Trials for BioNTech in Poland | ||
03.09. | Ori Biotech's IRO Platform Receives FDA AMT Designation | ||
03.09. | Experic Taps Jeffrey Shane as Chief Commercial Officer | ||
03.09. | Cytovance Biologics Expands Services with In-House Formulation Development | ||
03.09. | CPTx Appoints David Maier to Lead gxstrands Business Unit | ||
02.09. | Curida Launches New Unified Brand Identity | ||
02.09. | Grand River Aseptic Manufacturing Names New CEO | ||
02.09. | RareMed Solutions Expands Relationship with PTC Therapeutics |